Prevalence of Hypertension in Patients with Chronic Obstructive Pulmonary Disease Attending Respiratory Medicine OPD

Author(s):  
Dr Rohit Singh ◽  
Author(s):  
Chantal Simon ◽  
Hazel Everitt ◽  
Françoise van Dorp ◽  
Matt Burkes

Breathlessness Cough Chest signs Other signs of respiratory disease Respiratory investigations Bronchodilators and steroids Asthma in adults Asthma management in practice Drug treatment of asthma Chronic obstructive pulmonary disease Management of COPD Acute exacerbations of COPD Lung cancer Colds and influenza Pneumonia in adults Tuberculosis...


2021 ◽  
Vol 46 (3) ◽  
pp. 204-210
Author(s):  
Muhammad Mohiuddin ◽  
Abdul Wadud Chowdhury ◽  
Kazi Nazrul Islam ◽  
Mohammad Gaffar Amin ◽  
Abu Thaher Mohammad Mahfuzul Hoque ◽  
...  

Background: Chronic Obstructive Pulmonary Disease (COPD) is a global health burden having systemic and extrapulmonary manifestations. Among them cardiovascular changes are the major comorbidity associated with COPD, responsible for significant morbidity and mortality. Echocardiography is one of the simplest and noninvasive tools in assessing these changes. Objective: To evaluate the echocardiographic changes in patients with chronic obstruction palmonary disease. Methods: A cross sectional observational study was carried out in Department of Cardiology and Department of Respiratory Medicine, Dhaka Medical College Hospital from July, 2018 to June, 2019. Total 98 COPD patients were included in the study. They underwent spirometry in Department of Respiratory Medicine and echocardiography in Department of Cardiology. Data was collected from the patients and recorded in a structured report form. Results: Significant echocardiographic abnormalities were present in 51.02% patients. Most common echocardiographic change was pulmonary hypertension (43.9%). Other echocardiographic findings were dilated RA & RV (36.7%), RVH (35.7%), LV diastolic dysfunction (30.6%) and RV systolic dysfunction (9.2%). Echocardiographic signs of pulmonary hypertension, dilated RA & RV, RVH, RV systolic dysfunction and LV diastolic dysfunction were correlated with the severity of the disease. Though echocardiographic change of pulmonary hypertension was uncommon in COPD stage 1 & 2, but it was very common in stage 3(45.7%) & stage 4(92.9%). Conclusion: This study showed that echocardiographic changes were very common among the COPD GOLD stage 3 & 4 patients. Though these changes were infrequent among mild COPD patients but their severity increased with increasing stage of COPD. Bangladesh Med Res Counc Bull 2020; 46(3): 204-210


2020 ◽  
Vol 15 ◽  
Author(s):  
Ilaria Aredano ◽  
Francesca De Blasio ◽  
Paola Berchialla ◽  
Luisa Brussino ◽  
Caterina Bucca ◽  
...  

On behalf of the coauthors and with much regret, I must retract our publication entitled "Determinants of self-reported adherence to inhaler therapy in patients with chronic obstructive pulmonary disease", published in Multidisciplinary Respiratory Medicine 2020;15:654 DOI: https://doi.org/10.4081/mrm.2020.654 The reason for the retraction is a complaint by MMAS Research LLC because of the breaching of the IRS Morisky Widget License. Prof. Caterina BuccaRetired Professor of Respiratory MedicineDept. Medical SciencesUniversity of TurinItaly


Author(s):  
Pugazhendhi Selvam ◽  
Subramani Suriyan ◽  
Rowhit Yanamadala ◽  
Rathish Manimohan ◽  
Vandhana Pagadal ◽  
...  

Introduction: Non-invasive Mechanical Ventilation (NIV) is a better alternative for treating respiratory failures of any cause compared to invasive ventilation. Various factors influence the outcomes of patients treated with NIV in acute respiratory failure secondary to Chronic Obstructive Pulmonary Disease (COPD). Aim: To determine the possible early predictors and associated factors influencing the outcome of NIV in acute respiratory failure due to COPD patients. Materials and Methods: This was hospital-based observational study undertaken at SRM Medical Hospital and Research Centre in the Respiratory Medicine Department, after obtaining ethical clearance and informed patient consent. All patients with COPD exacerbation were admitted to the respiratory medicine ward. An Arterial Blood Gas (ABG) analysis was carried out, and those patients with type 2 respiratory failure were included in the study. This study included 42 patients with acute respiratory failure secondary to COPD requiring NIV. Data of patient's ABG parameter, heart rate, blood pressure, and respiratory rate baseline values were noted and at an interval of one hour, six hours, and every 24 hours were recorded. The outcome was divided into two categories depending upon whether patients improved or required invasive ventilation. Data were entered in Microsoft Excel datasheet and was analysed using Statistical Package For The Social Sciences (SPSS) 22 version software. Results: Of 42 patients, 30 (71.42%) were treated successfully with NIV, while 12(28.57%) required invasive ventilation and were declared NIV failure (requiring invasive ventilation). Among the patients, it was observed that patients with mean age >60 years, BMI >26.5, baseline pH <7.2, PaCO2 >78, heart rate >120, respiratory rate >40, co-morbidities and infective exacerbation were requiring invasive ventilation. It was also observed that among the failure category patients treated with conventional Spontaneous and Timed (S/T) mode showed more failure rates than Average Volume Assured Pressure Support (AVAPS) S/T mode. Conclusion: Patients with acute respiratory failure secondary to COPD responds well to NIV. The baseline pH, PaCO2, HR and Respiratory Rate (RR) before initiation of NIV predicts outcome. Also, age, BMI, associated comorbidities and mode of NIV predicts the outcome.


2020 ◽  
Vol 29 (2) ◽  
pp. 864-872
Author(s):  
Fernanda Borowsky da Rosa ◽  
Adriane Schmidt Pasqualoto ◽  
Catriona M. Steele ◽  
Renata Mancopes

Introduction The oral cavity and pharynx have a rich sensory system composed of specialized receptors. The integrity of oropharyngeal sensation is thought to be fundamental for safe and efficient swallowing. Chronic obstructive pulmonary disease (COPD) patients are at risk for oropharyngeal sensory impairment due to frequent use of inhaled medications and comorbidities including gastroesophageal reflux disease. Objective This study aimed to describe and compare oral and oropharyngeal sensory function measured using noninstrumental clinical methods in adults with COPD and healthy controls. Method Participants included 27 adults (18 men, nine women) with a diagnosis of COPD and a mean age of 66.56 years ( SD = 8.68). The control group comprised 11 healthy adults (five men, six women) with a mean age of 60.09 years ( SD = 11.57). Spirometry measures confirmed reduced functional expiratory volumes (% predicted) in the COPD patients compared to the control participants. All participants completed a case history interview and underwent clinical evaluation of oral and oropharyngeal sensation by a speech-language pathologist. The sensory evaluation explored the detection of tactile and temperature stimuli delivered by cotton swab to six locations in the oral cavity and two in the oropharynx as well as identification of the taste of stimuli administered in 5-ml boluses to the mouth. Analyses explored the frequencies of accurate responses regarding stimulus location, temperature and taste between groups, and between age groups (“≤ 65 years” and “> 65 years”) within the COPD cohort. Results We found significantly higher frequencies of reported use of inhaled medications ( p < .001) and xerostomia ( p = .003) in the COPD cohort. Oral cavity thermal sensation ( p = .009) was reduced in the COPD participants, and a significant age-related decline in gustatory sensation was found in the COPD group ( p = .018). Conclusion This study found that most of the measures of oral and oropharyngeal sensation remained intact in the COPD group. Oral thermal sensation was impaired in individuals with COPD, and reduced gustatory sensation was observed in the older COPD participants. Possible links between these results and the use of inhaled medication by individuals with COPD are discussed.


Sign in / Sign up

Export Citation Format

Share Document